Showing results (561-570 of 1,155) with videos related to
Sort By:
Pageof 116
Gynecologic Oncology|July 1, 1994
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinomaB J Monk, D S Cha, J L Walker, et al.Archives of Gynecology and Obstetrics|March 19, 2020
Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?Dimitrios Nasioudis, Benjamin B Albright, Emily M Ko, et al.Diseases of the Colon and Rectum|March 2, 2021
Persistent High Rate of Positive Margins and Postoperative Complications After Surgery for cT4 Rectal Cancer at a National LevelLindsey C F de Nes, Luuk D Drager, Marlies G Verstegen, et al.Cancers|August 7, 2021
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma PatientsKen Kudura, Florentia Dimitriou, Lucas Basler, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
PET/MR imaging of bone lesions--implications for PET quantification from imperfect attenuation correctionAndrei Samarin, Cyrill Burger, Scott D Wollenweber, et al.Anticancer Research|August 6, 2000
Evaluation of the antitumor activity of 1-(3-C-ethynyl-beta-D-ribofuranosyl) (PJ272), a recent ribonucleoside analogueV Holl, P Jung, D Weltin, et al.Molecular and Chemical Neuropathology|May 1, 1996
Immunogenetic studies in autism and related disordersR P Warren, V K Singh, R E Averett, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2016
Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in childrenA J Garcia-Prats, L du Plessis, H R Draper, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 3, 2019
Hospital volume and outcome in rectal cancer patients; results of a population-based study in the NetherlandsJ A W Hagemans, W J Alberda, M Verstegen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemiaXavier C Badoux, Michael J Keating, Sijin Wen, et al.Pageof 116